Active Ingredient History
Iron(II,III) oxide is the chemical compound with formula Fe3O4. It occurs in nature as the mineral magnetite. It is one of a number of iron oxides, the others being iron(II) oxide (FeO), which is rare, and iron(III) oxide (Fe2O3) which also occurs naturally as the mineral hematite. It contains both Fe2+ and Fe3+ ions and is sometimes formulated as FeO ∙ Fe2O3. This iron oxide is encountered in the laboratory as a black powder. It exhibits permanent magnetism and is ferrimagnetic, but is sometimes incorrectly described as ferromagnetic. Its most extensive use is as a black pigment. For this purpose, it is synthesized rather than being extracted from the naturally occurring mineral as the particle size and shape can be varied by the method of production. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Accidents (Phase 1)
AIDS Dementia Complex (Phase 2)
Anemia (Phase 4)
Anemia, Iron-Deficiency (Phase 4)
Brain Injuries (Early Phase 1)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cardiovascular Diseases (Phase 1/Phase 2)
Central Nervous System Diseases (Phase 1)
Central Nervous System Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Cranial Nerve Diseases (Phase 2)
Dental Caries (Early Phase 1)
Diagnostic Imaging (Phase 2)
Esophageal Neoplasms (Phase 2)
Fetal Growth Retardation (Early Phase 1)
Glioblastoma (Phase 2)
Head and Neck Neoplasms (Early Phase 1)
Healthy Volunteers (Phase 2/Phase 3)
Heart Diseases (Phase 4)
Heart Transplantation (Phase 3)
Hemorrhage (Phase 1)
Hypoxia (Early Phase 1)
Inflammation (Phase 4)
Intracranial Aneurysm (Phase 1)
Intracranial Arteriosclerosis (Phase 1)
Iron Deficiencies (Phase 4)
Kidney Diseases (Phase 2)
Kidney Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Menorrhagia (Phase 4)
Multiple Sclerosis (Early Phase 1)
Myocarditis (Phase 2/Phase 3)
Neoplasms (Phase 1)
Nervous System Diseases (Phase 2)
Osteonecrosis (Phase 4)
Oxidative Stress (Phase 4)
Peripheral Arterial Disease (Phase 2)
Pregnancy Complications (Phase 4)
Prostatic Neoplasms (Phase 2)
Pulmonary Embolism (Phase 1/Phase 2)
Restless Legs Syndrome (Phase 2)
Stroke (Phase 1)
Triple Negative Breast Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
